An Important, Common, and Easily Treatable Cardiovascular Risk Factor?
暂无分享,去创建一个
J. O’Keefe | M. Holick | D. Hensrud | John H. Lee | D. Bell
[1] Z. Mahfoud,et al. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. , 2008, The Journal of clinical endocrinology and metabolism.
[2] Stefan Pilz,et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.
[3] E. Rimm,et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.
[4] P. Raggi,et al. Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004 , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[5] R. Tilvis,et al. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. , 2008, European journal of endocrinology.
[6] S. Booth,et al. Vitamin D3 in fat tissue , 2008, Endocrine.
[7] A. Akobeng,et al. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.
[8] J. Sugden,et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[9] M. Holick,et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.
[10] K. Kalantar-Zadeh,et al. Association of activated vitamin D treatment and mortality in chronic kidney disease. , 2008, Archives of internal medicine.
[11] Michael J. Pencina,et al. Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.
[12] Graeme Jones,et al. Cardiovascular risks of calcium supplements in women , 2008, BMJ : British Medical Journal.
[13] P. Barber,et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial , 2008, BMJ : British Medical Journal.
[14] B. Mitchell,et al. Decreased Bone Mineral Density Is Correlated with Increased Subclinical Atherosclerosis in Older, but not Younger, Mexican American Women and Men: The San Antonio Family Osteoporosis Study , 2007, Calcified Tissue International.
[15] M. Wolf,et al. Vitamin D levels and early mortality among incident hemodialysis patients. , 2007, Kidney international.
[16] N. Singh,et al. Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.
[17] Sara Gandini,et al. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.
[18] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[19] M. Sowers,et al. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.
[20] Keith C. Norris,et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.
[21] M. Holick,et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.
[22] R. Simpson,et al. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[23] K. Kalantar-Zadeh,et al. Impact of kidney bone disease and its management on survival of patients on dialysis. , 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[24] A. Shao,et al. Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.
[25] Stylianos N. Zerefos,et al. Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis , 2007, International Urology and Nephrology.
[26] P. Lips. Vitamin D physiology. , 2006, Progress in biophysics and molecular biology.
[27] A. Zittermann. Vitamin D and disease prevention with special reference to cardiovascular disease. , 2006, Progress in biophysics and molecular biology.
[28] W. Willett,et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.
[29] G. Tenderich,et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.
[30] G. Targher,et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.
[31] J. Manson,et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.
[32] F. Pattou,et al. 1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor , 2006, Apoptosis.
[33] E. Warburton,et al. Reduced Vitamin D in Acute Stroke , 2006, Stroke.
[34] H. Vestergaard,et al. Increased plasma N‐terminal pro‐B‐type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism , 2005, Clinical endocrinology.
[35] P. Raggi,et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] M. Sowers,et al. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.
[37] M. Holick. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.
[38] B. Hollis,et al. Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.
[39] E. Rydberg,et al. Primary hyperparathyroidism and heart disease--a review. , 2004, European heart journal.
[40] M. Saad,et al. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .
[41] Bess Dawson-Hughes,et al. Effect of Vitamin D on falls: a meta-analysis. , 2004, JAMA.
[42] M. Holick,et al. Vitamin D intake in the United States. , 2003, Journal of the American Dietetic Association.
[43] G. Plotnikoff,et al. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. , 2003, Mayo Clinic proceedings.
[44] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[45] P. Vestergaard,et al. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism , 2003, BMJ : British Medical Journal.
[46] Yan Chun Li. Vitamin D regulation of the renin–angiotensin system , 2003, Journal of cellular biochemistry.
[47] M. Holick,et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.
[48] M. Holick,et al. Vitamin D insufficiency among free-living healthy young adults. , 2002, The American journal of medicine.
[49] B. Dawson-Hughes,et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.
[50] D. Wheeler,et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.
[51] Elina Hyppönen,et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.
[52] T. Chen,et al. Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.
[53] M. Holick,et al. Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.
[54] H. Glerup,et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.
[55] R. Vieth,et al. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.
[56] Arya M. Sharma,et al. Ultraviolet B and blood pressure , 1998, The Lancet.
[57] K. Watson,et al. Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.
[58] S. Rostand. Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1997, Hypertension.
[59] R. Morris,et al. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. , 1991, The Journal of clinical investigation.
[60] R. Beaglehole,et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.
[61] M. Holick,et al. Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.
[62] J. Adams,et al. INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.